NNOXEarnings

Nanox furnishes preliminary Q3 2026 revenue of approximately $4.3-$4.4 million; going-concern flag raised

Nano-X Imaging Ltd. furnished preliminary unaudited revenue of approximately $4.3 to $4.4 million for the three months ended September 30, 2026, compared with $3.4 million in the third quarter of 2025. Preliminary cash, cash equivalents, short-term deposits and long-term restricted deposits were approximately $26.0 million as of September 30, 2026 versus $60.0 million as of December 31, 2025. Management stated that available cash and deposits are not sufficient to support operations for at least one year, raisin...

Published October 16, 2026 at 4:18 PM EDTNano-X Imaging Ltd.SEC filing

Share this story

Key takeaways

Going-concern flag: management said approximately $26.0 million in cash and deposits as of September 30, 2026 is insufficient to fund operations under current plans for at least one year.
Cash and deposits declined from $60.0 million at December 31, 2025 to approximately $26.0 million at September 30, 2026, a reduction of approximately $34.0 million in nine months.
Preliminary Q3 2026 revenue of approximately $4.3-$4.4 million is up versus $3.4 million in Q3 2025; AI and software solutions revenue contributed $1.0 million (vs $0.1 million), driven by the consolidation of Vaso Healthcare IT Inc. (now Nanox Health IT Inc.).
Imaging systems and OEM services revenue rose to approximately $0.3 million (vs $0.2 million) on an additional Nanox.ARC CapEx agreement, while teleradiology services held flat at approximately $3.1 million.
Business update: Nanox.AI signed a distribution agreement with Technologic s.r.l. (affiliate of Tecnologie Avanzate) to commercialize the Nanox.AI Bone Solution in Italy.
Business update: Nanox.ARC X was included in TIME's Best Inventions of 2026.
Preliminary figures only: final unaudited Q3 2026 results have not yet been furnished and may differ materially.

Key metrics

Total revenue (preliminary, unaudited)Three months ended September 30, 2026

$4.3-$4.4 million+26.5% to +29.4% vs $3.4 million in Q3 2025 (midpoint +28%)

Teleradiology services revenueThree months ended September 30, 2026

approximately $3.1 millionFlat vs $3.1 million in Q3 2025

Imaging systems and OEM services revenueThree months ended September 30, 2026

approximately $0.3 million+50% vs $0.2 million in Q3 2025

AI and software solutions revenueThree months ended September 30, 2026

$1.0 million+900% vs $0.1 million in Q3 2025

Cash, cash equivalents, short-term deposits and long-term restricted deposits (preliminary, unaudited)As of September 30, 2026

approximately $26.0 millionvs $60.0 million as of December 31, 2025

Going-concern indicationAs of October 16, 2026

Substantial doubt about ability to continue as a going concern

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

All NNOX coverage

BPEarnings

BP Q3 2026 Oil production & operations underlying RC profit before interest and tax $3.534 billion, Beat Guidance by +$1.36B

BTSGEarnings

BTSG Q3 2026 Total Revenue $4,213 million, Beat Guidance by +$397.4M

CVXEarnings

Chevron Q3 2026 earnings $9.9B on strong downstream margins, raises dividend

FFAICompany update

FFR October Robot Sales: 351 Units, Cumulative Reaches 1,168, Guidance Maintained at ~2,000 for FY2026

Follow NNOX in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert